S-3 ·Filed Nov 16, 2026
Shelf registration (potential dilution)
MPLT drugs
MPLT drug pipeline →Price Chart
Loading chart...
Investment Themes
Documents Analyzed
This report is based on 2 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3 Filing (Primary) | 0001193125-26-462295 |
| Document: d452593dex42.htm | 0001193125-26-462295 |
Track record
36 reports on MPLT
5 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +57.24% at T+60 after the May 18, 2026 report. 6 of 7 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Bearish 5/10 Entry $6.97 Now $6.90 +0.93% settles Dec 15
- Nov 16, 2026today 8-K Neutral 3/10 Entry $7.34 Now $6.90 −5.99% settles Dec 15
- Nov 16, 2026today S-3 Neutral 4/10 Viewing Entry $7.37 Now $6.90 −6.38% settles Dec 15
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $7.37 Now $6.90 −6.38% settles Dec 15
- Nov 16, 2026today Press Release Bullish 5/10 Entry $7.37 Now $6.90 −6.38% settles Dec 15
- Oct 16, 20264w ago Insider Cluster Bearish 4/10 Entry $8.00 to $6.90 Now $6.90 +13.75% ▲ +13.75% +10.29% vs SPY
- Oct 15, 20264w ago 144 Neutral 2/10 Entry $7.70 to $7.25 Now $6.90 −10.39% ▼ −5.84% −4.68% vs SPY
- Oct 15, 20264w ago 144 Neutral 2/10 Entry $7.70 to $7.25 Now $6.90 −10.39% ▼ −5.84% −4.68% vs SPY
- Oct 15, 20264w ago 144 Neutral 2/10 Entry $7.70 to $7.25 Now $6.90 −10.39% ▼ −5.84% −4.68% vs SPY
- Sep 24, 20267w ago EFFECT Neutral 4/10 Entry $10.76 to $8.25 Now $6.90 −35.87% ▼ −23.33% −22.91% vs SPY
Showing 10 of 36
US Market Status
Market Closed · Opens in 8h 9m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers